RS Research

RS Research Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.4M
Latest Deal Amount
  • Investors
  • 1

RS Research General Information


Operator of novel nanomedicines research platform intended to develop next-generation therapeutics. The company's novel nanomedicines research platform has developed a pioneering class of nanocarriers that can be used in various proprietary programs in various stages of preclinical development for the treatment of cancer, enabling medical institutions and research laboratories to develop targeted medicines in an advanced and speedy way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Social/Platform Software
Primary Office
  • Teknopark Istanbul
  • Sanayi Mah. Teknopark Blv., No:1/2A-401 34912
  • 34912 Istanbul
  • Turkey
+90 0535 000 00 00

RS Research Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RS Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 18-Jan-2018 $2.4M 00.000 Completed Generating Revenue
1. Seed Round 17-Apr-2017 00.000 00.000 Completed Generating Revenue

RS Research Executive Team (2)

Name Title Board Seat Contact Info
Sena Nomak Co-Founder & Chief Operating Officer
Rana Sanyal Co-Founder & Chief Science Officer

RS Research Investors (1)

To view RS Research‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ACT Venture Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial